LYBALVI

Alkermes Pharma Ireland Limited

Application Filed: 2021-02-22
Trademark Application Details
Trademark Logo LYBALVI

Mark For: LYBALVI™ trademark registration is intended to cover the categories of pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia. [all]

Status

2021-02-27 UTC
LIVE APPLICATION Awaiting Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and has not yet been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number90538254
Mark Literal ElementsLYBALVI
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationNEW APPLICATION PROCESSING 2021-02-25
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 005: Adhesives
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Domestic RepresentativeNorm J. Rich
Attorney NameNorm J. Rich
Attorney Docket Number029318-2833

Timeline

2021-02-22Application Filed
2021-02-25Location: NEW APPLICATION PROCESSING
2021-02-25Status: Live/Pending
2021-02-25Status: New application will be assigned to an examining attorney approximately 3 months after filing date.
2021-02-25Transaction Date

Trademark Parties (Applicants & Owners)

Party: Alkermes Pharma Ireland Limited
AddressConnaught House 1 Burlington Road Dublin IRELAND
Legal Entity TypeCorporation
Legal Entity StateIRELAND

Documents

ApplicationMULTI2021-02-22
DrawingIMAGE/JPEG2021-02-22

Attorney of Record

NORM J. RICH
FOLEY & LARDNER LLP
3000 K STREET, N.W.
SIXTH FLOOR
WASHINGTON, DC 20007

Good, Services, and Codes


IC 005. US 005 006 018 044 046 051 052. G & S: Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia

International Codes:5
U.S. Codes:005,006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations for the treatment of psychiatric and neurodegenerative diseases and disorders including schizophrenia, depression, major depressive disorder, stress, anxiety, treatment resistant depression, bipolar depression, bipolar disorder; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidemia

Trademark Filing History

DescriptionDateProceeding Number
NEW APPLICATION ENTERED IN TRAM2021-02-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed